These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 29377193

  • 41. Infection as a Trigger for Portal Hypertension.
    Steib CJ, Schewe J, Gerbes AL.
    Dig Dis; 2015; 33(4):570-6. PubMed ID: 26159275
    [Abstract] [Full Text] [Related]

  • 42. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.
    Tey TT, Gogna A, Irani FG, Too CW, Lo HG, Tan BS, Tay KH, Lui HF, Chang PE.
    Singapore Med J; 2016 Mar; 57(3):132-7. PubMed ID: 26996384
    [Abstract] [Full Text] [Related]

  • 43. Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension.
    Ebel NH, Carlin K, Shaffer ML, Shivaram G, Hawkins M, Lane ER, Cooper K, Lindquester WS, Gadodia G, Murray KF.
    J Pediatr Gastroenterol Nutr; 2019 Jun; 68(6):788-792. PubMed ID: 30921261
    [Abstract] [Full Text] [Related]

  • 44. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C.
    J Clin Gastroenterol; 2007 Jun; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [Abstract] [Full Text] [Related]

  • 45. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, Bureau C.
    J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
    [Abstract] [Full Text] [Related]

  • 46. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
    Pár G, Trosits A, Pakodi F, Szabó I, Czimmer J, Illés A, Gódi S, Bajor J, Sarlós P, Kenyeres P, Miseta A, Vincze A, Pár A.
    Orv Hetil; 2014 Feb 16; 155(7):270-6. PubMed ID: 24509356
    [Abstract] [Full Text] [Related]

  • 47. Prognostic evaluation of patients with acute variceal bleeding.
    Augustin S, Millán L, González A, Coll M, Martell M, Genescà J.
    Dis Markers; 2011 Feb 16; 31(3):155-64. PubMed ID: 22045401
    [No Abstract] [Full Text] [Related]

  • 48. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.
    Schwarzer R, Reiberger T, Mandorfer M, Kivaranovic D, Hametner S, Hametner S, Paternostro R, Scheiner B, Schneeweiss-Friedl J, Trauner M, Schoefl R, Maieron A.
    J Gastroenterol; 2020 May 16; 55(5):533-542. PubMed ID: 31832759
    [Abstract] [Full Text] [Related]

  • 49. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A, Azzaroli F, Cucchetti A, Buonfiglioli F, Cecinato P, Calvanese C, Simoni P, Arena R, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G.
    Liver Int; 2016 Sep 16; 36(9):1313-21. PubMed ID: 26786880
    [Abstract] [Full Text] [Related]

  • 50. [The role of upper gastrointestinal endoscopy in evaluation of portal hypertension].
    Melinte-Popescu M, Bălan G.
    Rev Med Chir Soc Med Nat Iasi; 2011 Sep 16; 115(4):1003-6. PubMed ID: 22276436
    [Abstract] [Full Text] [Related]

  • 51. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.
    Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, Bosch J, Garcia-Pagan JC.
    Am J Gastroenterol; 2009 Jul 16; 104(7):1707-14. PubMed ID: 19471257
    [Abstract] [Full Text] [Related]

  • 52. The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.
    Laursen TL, Rødgaard-Hansen S, Møller HJ, Mortensen C, Karlsen S, Nielsen DT, Frevert S, Clemmesen JO, Møller S, Jensen JS, Bendtsen F, Grønbaek H.
    Liver Int; 2017 Apr 16; 37(4):569-575. PubMed ID: 27706896
    [Abstract] [Full Text] [Related]

  • 53. Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients.
    Wu PS, Hsieh YC, Lee KC, Huang YH, Hou MC, Lin HC.
    PLoS One; 2021 Apr 16; 16(10):e0258589. PubMed ID: 34648567
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Prognostic value of early measurements of portal pressure in acute variceal bleeding.
    Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, Bosch J.
    Gastroenterology; 1999 Sep 16; 117(3):626-31. PubMed ID: 10464138
    [Abstract] [Full Text] [Related]

  • 56. Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis.
    Waidmann O, Brunner F, Herrmann E, Zeuzem S, Piiper A, Kronenberger B.
    J Hepatol; 2013 May 16; 58(5):956-61. PubMed ID: 23333526
    [Abstract] [Full Text] [Related]

  • 57. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J.
    Hepatology; 2010 Jun 16; 51(6):2108-16. PubMed ID: 20512998
    [Abstract] [Full Text] [Related]

  • 58. Relationship between elevation of glycated albumin to glycated hemoglobin ratio in patients with a high bleeding risk of esophageal varices.
    Sakai Y, Enomoto H, Aizawa N, Iwata Y, Tanaka H, Ikeda N, Takashima T, Takata R, Iwai T, Iwata K, Saito M, Imanishi H, Iijima H, Nakamura H, Nishiguchi S.
    Hepatogastroenterology; 2012 Oct 16; 59(119):2280-4. PubMed ID: 22440250
    [Abstract] [Full Text] [Related]

  • 59. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients.
    Kim TY, Suk KT, Jeong SW, Ryu T, Kim DJ, Baik SK, Sohn JH, Jeong WK, Choi E, Jang JY, Kim MY.
    J Korean Med Sci; 2019 Aug 26; 34(33):e223. PubMed ID: 31436052
    [Abstract] [Full Text] [Related]

  • 60. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
    Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, Lammert F, Trauner M, Peck-Radosavljevic M, Vogelsang H, Vienna Hepatic Hemodynamic Lab.
    J Hepatol; 2013 May 26; 58(5):911-21. PubMed ID: 23262249
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.